Substanzlinks

Pola-R-CHP - Polatuzumab Vedotin 1,8 / Rituximab 375 / Cyclophosphamid 750 / Doxorubicin 50 / Prednisolon 100, diffus großzellige B-Non-Hodgkin Lymphome, Zyklus 1-6 (PID1920 V1.0)

Cyclophosphamid (ATC L01AA01)

PC Compound: Cyclophosphamide
PC Substance: Cyclophospamid

Dimetinden (ATC R06AB03)

FachInfo: Dimentinden (Fenistil®, NOVARTIS, Dimetindenmaleat 1mg/ml, i.v.)
PC Compound: Dimetinden
PC Substance: Dimetinden
PC Substance: Dimetindenmaleat

Doxorubicin (ATC L01DB01)

FachInfo: Doxorubicin (Doxorubicinhydrochlorid Teva® 2 mg/ml, i.v.)
PC Compound: Doxorubicin
PC Substance: DoxorubicinHCl
Rote Liste: Doxorubicin

Granisetron (ATC A04AA02)

EMA EPAR: Granisetron (Sancuso, 3.1 mg/24 hours transdermal
EMA URL: Kytril, granisetron
FachInfo: Granisetron (Granisetron Kabi, 1 mg/ml, i.v.)
PC Compound: Granisetron
PC Substance: Granisetron

Mesna (ATC V03AF01)

FachInfo: Mesna (Uromitexan®, Baxter Oncology, 400 mg, i.v.)
FachInfo: Mesna (Uromitexan, Baxter Oncology, Tbl. 400mg, 600mg, p.o.)
PC Compound: Mesna
PC Substance: Mesna
Rote Liste: Mesna
URL: Mesna WHO 2009

Paracetamol (ATC N02BE01)

PC Compound: Paracetamol

Pegfilgrastim (ATC L03AA13)

EMA EPAR: Pegfilgrastim (neulasta)
FachInfo: Pegfilgrastim (Neulasta®, AMGEN, 6 mg, s.c.)
PC Substance: Pegfilgrastim
PC Substance: Pegfilgrastim
Rote Liste: Pegfilgrastim

Polatuzumab Vedotin (ATC L01FX14)

EMA EPAR: Polatuzumab vedotin (polivy)
FachInfo: Polatuzumab Vedotin (Polivy, Roche, 140 mg, i.v.)
PC Substance: Polatuzumab vedotin

Prednisolon (ATC H02AB06)

PC Compound: Prednisolone

Rituximab (ATC L01FA01)

EMA EPAR: Rituximab (mabthera)
FachInfo: Rituximab (MabThera® 100 mg, Roche, MabThera® 500 mg, i.v.)
FachInfo: Rituximab (MabThera®, Roche, 1.400 mg, s.c.)
PC Substance: Rituximab
PC Substance: Rituximab
PEI : Rote Hand Brief - Rituximab (MabThera®): HBV Screening vor Behandlung (11/2013), Informationen zu Stevens-Johnson-Syndrom (04/2013), Tödliche infusionsbedingte Reaktionen bei Patienten mit RA (08/2011)
Rote Liste: Rituximab